Search

everythinglearnresearchcommunity

for

Search:↓

Men born very underweight had higher estrogen levels but normal reproduction compared to normal birth weight men.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Minoxidil and finasteride are effective for male hair loss; minoxidil also helps female hair loss, with some treatments needing more research.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

Balding men had lower bone density, while balding women had higher hip bone density.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Dutasteride for hair loss might increase the risk of a rare stroke type.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

Oral contraceptives and antiandrogens are effective for treating hirsutism, with antiandrogens being the most effective.

Insulinomas and adrenocortical tumors are common in older ferrets, diagnosed with blood tests and ultrasounds, and treated with medications or surgery.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Hormones and stretching both needed for nipple area skin growth in mice.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Women with acne and PCOS should be checked for insulin resistance and related symptoms.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Neurosteroids help regulate oxytocin levels, especially during stress and pregnancy, to protect against premature labor.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

The 2024 guideline updates recommendations for genetic testing, imaging, and sperm retrieval in male infertility.